Identification of an imidazoline-guanidinium receptive site in mitochondria from rabbit cerebral cortex.

Abstract

In the present report, we used [3H]idazoxan to characterize imidazoline-guanidinium receptive sites (IGRS) in mitochondria from rabbit cerebral cortex. When compared to the starting homogenate, [3H]idazoxan binding was higher (1.161 +/- 0.159 vs. 0.102 +/- 0.024 pmol/mg of protein) in a membrane fraction 6-fold enriched in cytochrome oxidase activity, a specific marker for mitochondria. In addition, the enrichment of [3H]idazoxan binding sites positively correlates with cytochrome oxidase activity in different membrane preparations (r = 0.977, P less than 0.001). In competition studies, [3H]idazoxan binding was completely inhibited by imidazoline and guanidinium derivatives but not affected by 10 microM epinephrine. Taken together, these data show the localization of IGRS in the mitochondria from rabbit cerebral cortex.

Statistics

0200400600'97'99'01'03'05'07'09'11'13'15'17
Citations per Year

630 Citations

Semantic Scholar estimates that this publication has 630 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Tesson1991IdentificationOA, title={Identification of an imidazoline-guanidinium receptive site in mitochondria from rabbit cerebral cortex.}, author={F. Tesson and Angelo Parini}, journal={European journal of pharmacology}, year={1991}, volume={208 1}, pages={81-3} }